These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8768921

  • 1. Role of volume overload in dialysis-refractory hypertension.
    Fishbane S, Natke E, Maesaka JK.
    Am J Kidney Dis; 1996 Aug; 28(2):257-61. PubMed ID: 8768921
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Digitalislike immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients.
    Bisordi JE, Holt S.
    Am J Kidney Dis; 1989 May; 13(5):396-403. PubMed ID: 2541609
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
    Takagi T, Nishikawa M, Inada M.
    Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. B-type natriuretic peptide is not a volume marker among patients on hemodialysis.
    Agarwal R.
    Nephrol Dial Transplant; 2013 Dec; 28(12):3082-9. PubMed ID: 23525529
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis.
    Plum J, Grabensee B.
    J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
    Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma endothelin-1 in hemodialysis treatment - the influence of hypertension.
    Stefanidis I, Wurth P, Mertens PR, Ikonomov V, Philippidis G, Golphinopoulos S, Makropoulos V, Liakopoulos V, Mann H, Heintz B.
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S43-8. PubMed ID: 15838340
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
    Korzets Z, Pomeranz M, Shilo L, Pomeranze A, Levi A, Shenkman L, Berheim J.
    Adv Perit Dial; 1989 Nov; 5():20-3. PubMed ID: 2577411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.